Balanced news tone
News Sentiment
AMGN sentiment intelligence
Amgen Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-5.2% over one week, +6.4% over four weeks, trend active, and near fair-value range.
SteelPeak Wealth LLC Acquires 20,118 Shares of Amgen Inc. $AMGN
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
SteelPeak Wealth LLC Acquires 20,118 Shares of Amgen Inc. $AMGN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 10:25
- Source
- MarketBeat
Assetmark Inc. Purchases 15,719 Shares of Amgen Inc. $AMGN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 07:31
- Source
- MarketBeat
Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- G
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:25
- Source
- GuruFocus
Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:02
- Source
- MarketBeat
Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 07:23
- Source
- MarketBeat
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 21:50
- Source
- Market source
Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 15:13
- Source
- Market source
Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 10:21
- Source
- MarketBeat
Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 07:32
- Source
- MarketBeat
Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here’s What It Means for the Stock.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 16:09
- Source
- TIKR.com
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 13:00
- Source
- Market source
Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 13 Jul 2026 12:49
- Source
- MarketBeat
Guggenheim raises Amgen stock price target to $343 on product mix
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 12:16
- Source
- Investing.com
BofA raises Amgen stock price target on growth franchise execution
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 13 Jul 2026 10:34
- Source
- Investing.com
Amgen (AMGN) Analyst Ratings, Stock Forecast and Price Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 13 Jul 2026 03:09
- Source
- Moomoo
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Amgen (AMGN) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
+3.35% for Amgen stock as Gilpin, ING Groep NV, Motley Fool increase holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Traders Union
Amgen shares dip amid rising selling pressure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Traders Union
Amgen (AMGN) Stock Climbs on MariTide Weight-Loss Drug Momentum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- parameter.io
Amgen (AMGN) Stock: Rises on $840M Dark Blue Therapeutics Acquisition Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jan 2026 08:00
- Source
- parameter.io
Amgen speaks out about bone density concerns with obesity drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Nov 2024 08:00
- Source
- Clinical Trials Arena
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 04 Aug 2022 07:00
- Source
- Reuters